{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T05:57:26Z","timestamp":1648533446125},"reference-count":12,"publisher":"The Japan Geriatrics Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. geriat","Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat"],"published-print":{"date-parts":[[2003]]},"DOI":"10.3143\/geriatrics.40.22","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T05:49:35Z","timestamp":1175060975000},"page":"22-26","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers, mild cognitive impairment and early diagnosis of Alzheimer's disease"],"prefix":"10.3143","volume":"40","author":[{"given":"Hiroyuki","family":"Arai","sequence":"first","affiliation":[{"name":"Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Petersen RC, Smith GE, Waring SC, et al.: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.","DOI":"10.1001\/archneur.56.3.303"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gomez-Isla T, Price JL, McKeel DW, et al.: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996; 16: 4491-4500.","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Price JL, Morris JC: Tangles and plaques in nondemented aging and &ldquo;preclinical&rdquo; Alzheimer's disease. Ann Neurol 1999; 45: 358-368.","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Terajima M, Arai H, Itabashi S, et al.: Elevated cerebrospinal fluid tau levels; implications for the early diagnosis of Alzheimer's disease. J Am Geriat Soc 1996; 44: 1012-1013.","DOI":"10.1111\/j.1532-5415.1996.tb01885.x"},{"key":"5","unstructured":"5) Arai H, Nakagawa T, Kosaka Y, et al.: Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals. Alzheimer's Res 1997; 3: 211-213."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ishiguro K, Ohno H, Arai H, et al.: Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci Lett 1999; 270: 91-94.","DOI":"10.1016\/S0304-3940(99)00476-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Arai H, Ishiguro K, Ohno H, et al.: CSF phosphorylated tau protein and mild cognitive impairment; a prospective study. Exp Neurol 2000; 166: 201-203.","DOI":"10.1006\/exnr.2000.7501"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Maruyama M, Arai H, Sugita M, et al.: Cerebrospinal fluid amyloid &beta;<sub>1-42<\/sub> levels in the mild cognitive impairment stage of Alzheimer's disease. Exp Neurol 2001; 172: 433-436.","DOI":"10.1006\/exnr.2001.7814"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Minoshima S, Giordani B, Berent S, et al.: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.","DOI":"10.1002\/ana.410420114"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Okamura N, Arai H, Maruyama M, et al.: A combined analysis of CSF-tau and IMP-SPECT in mild cognitive impairment; Implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002; 159: 474-476.","DOI":"10.1176\/appi.ajp.159.3.474"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Matsushita S, Arai H, Higuchi S, et al.: Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease. Biological Psychiatry in press, 2002.","DOI":"10.1016\/S0006-3223(02)01386-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lippa CF, Nee LE, Mori H, St George-Hyslop: A&beta;<sub>-42<\/sub> deposition precedes other changes in PS-1 Alzheimer's disease. Lancet 1998; 352: 1117-1118.","DOI":"10.1016\/S0140-6736(05)79757-9"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":["Biomarker \u7814\u7a76\u304b\u3089\u898b\u305f Mild cognitive impairment \u3068\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306e\u65e9\u671f\u8a3a\u65ad"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics1964\/40\/1\/40_1_22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:49:22Z","timestamp":1556308162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics1964\/40\/1\/40_1_22\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.40.22","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2003]]}}}